We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching among patients with psoriasis ...

Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may become altered, leading to a worsening of symptoms.

The distinct radiographic features of psoriatic arthritis (PsA) help confirm it as a distinct entity from rheumatoid arthritis and highlight some unique non-synovial based disease imaging features.

Psoriatic arthritis (PsA) is characterised by several unique clinical features that differentiate it from rheumatoid arthritis (RA). Attempts to identify immunopathological mechanisms, some shared ...

Payton Harris was going to the doctor's office for a routine health screening when they were met with unexpected news.

Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching and maintained long-term ...

Although Arthritis Today magazine is no longer published, sign up below to receive healthy living tips and resources in our Arthritis Today and other e-newsletters, delivered right to your inbox.

What is viscosupplementation treatment for arthritis? During viscosupplementation treatment for arthritis, your health care provider injects hyaluronic acid into your joint. This thick fluid may help ...

Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...